Corline Biomedical AB
SE0006887451 · FIRST NORTH SWEDEN
3 directors and managers of Corline Biomedical AB have disclosed 5 transactions under MAR Article 19: 4 buys worth €395k and 1 sell worth €9k, which reads as net buying. The most recent disclosed transaction was on 2026-08-26. The largest buy was Adam Dahlberg (Chairman of the Board of Directors) for €174k. See live cluster buys or start a free 14-day trial to get alerts when Corline Biomedical AB insiders trade.
Insiders
3
Net flow
€386k
Bought
€395k
Sold
€9k
Buy Corline Biomedical AB
Pick a broker. We handle the signal, they handle execution.
Affiliate links — we may earn a referral fee if you sign up.
All disclosed transactions
| Date | Type | Insider | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-26 1mo ago | SELL | Henrik Nittmar Chief Executive Officer (CEO)/Managing Directory | 6,557 | €1.39 | €9k |
| 2026-02-17 8mo ago | BUY | Henrik Nittmar Chief Executive Officer (CEO)/Managing Directory | 10,000 | €1.26 | €13k |
| 2024-11-08 1y ago | BUY | Adam Dahlberg Chairman of the Board of Directors | 333,333 | €0.52 | €174k |
| 2024-11-08 1y ago | BUY | Lars Sunnanvaeder Member of the Board of Directors | 333,333 | €0.52 | €174k |
| 2024-11-08 1y ago | BUY | Henrik Nittmar Chief Executive Officer (CEO)/Managing Directory | 66,666 | €0.52 | €35k |